Imatinib vs dasatinib

Common Questions and Answers about Imatinib vs dasatinib

gleevec

Avatar f tn Eithne01, The treatment of chronic myeloid leukemia (CML) has changed significantly since the late 1990s, with the development and subsequent approval by the Food and Drug Administration of imatinib (in 2001), the first of a class of medications called tyrosine kinase inhibitors, which target the specific abnormality that causes CML. Before that time, patients were treated with other therapy, including interferon and bone marrow transplant, and had very poor outcomes.
Avatar n tn It is possible that the white blood cell count would normalize after 2 weeks of taking Imatinib (Gleevec). Most responses to Imatinib are rapid since it targets the molecular pathogenetic event in CML. You may seek a second opinion if that will give you a peace of mind. Good luck.
1004138 tn?1316251113 lots of people die all the time because they reject traditional treatments and go with 'natural' things instead I would think of using alternatives along with regular treatments, but not in place of them. Some alternative things might have some benefit. Isn't homeopathy the approach where you dilute some substance down to one part per billion or so, and then expect it to actually have some curing power?
Avatar n tn Are you currently on any medication like imatinib? The neutropenia can be due to your current medication. You can ask your hematologist for G-CSF injection if you have persistent neutropenia. Patients with CML are immunocompromised and can easily acquire infections. Neutropenia also puts a patient in an immunocompromised state. For now, it is very important to prevent acquiring any infection. You should avoid crowded places and persons with ongoing infection. Good luck.
Avatar n tn Hi. Chronic Myelogenous Leukemia (CML) is a blood disorder caused by an acquired genetic defect in the pleripotent stem cell. It has several phases: indolent chronic or stable phase, aggressive or advanced phase, and accelerated and blastic phase. The transition between phases may take years (on the average, 4 to 6 years from the stable phase to aggressive phase).
Avatar f tn Average survival rates are generalizations, not applicable to a particular patient. The prognosis is relatively good. Newer techniques are being tried, including imatinib and stem cell transplantation. All the best, and God Bless!
Avatar f tn TY for the reply. Yes I was told and am thinking that its parasitc or allergy. I went to aruba in June but that wouldn't have an affect on me now, would it?
Avatar f tn Therapy with corticosteroids is used for the treatment of most and additional therapy is available and dependent upon the type of HS. Newer medicines such as imatinib and mepolizumab are said to be promising. So, should your son have HS, there is reason to be optimistic regarding a positive response to currently available therapy. You should request, of his doctor, an additional explanation for the tentative diagnosis of pre-hypertension. Good luck.
Avatar m tn Lactulose vs. Xifaxan to decrease the ammonia. And beta blockers vs. banding for the varices which I presume are esophageal. You will get variations of experiences here which are therapeutic relative to your anxiety and directive relative to the facts But go to your Hepatologist with these anxieties because you can manage the effects of cirrhosis. My best.
Avatar f tn You just have to do it awhile and you learn what is low vs high (ie knuckle deep to reach it vs full middle finger vs full ring finger). Then soft vs hard would be the difference between your lips and nose. I know way to much information, but you asked;-) It is also best when you cervix is wet (ie egg white stretchy discharge). Just remember most fertile is SHOW--Soft, High, Open, Wet. Again sorry I can't help with open vs closed. Good luck.
Avatar f tn Study Confirms Benefits of Vitamin E in Nonalcoholic Steatohepatitis Megan Brooks May 4, 2010 — Supplementation with the natural form of vitamin E (800 IU/day) has beneficial effects in patients with nonalcoholic steatohepatitis (NASH), but pioglitazone's benefits are less clear, according to the latest findings from the Pioglitazone vs Vitamin E vs Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis (PIVENS) trial, reported online April 28 in the New England
148588 tn?1465778809 [25] In the SUCCESS study, the intent-to-treat analysis showed that the SVR rate was slightly higher at 48% vs 43% with 72 vs 48 weeks of treatment, respectively, but the difference was not statistically significant (P = .6445). Of note, relapse rates were also not statistically significantly different between the 2 arms (33% vs 47% with 72 vs 48 weeks of therapy, respectively; P = .1699).
Avatar m tn Here is the article I was referring to. I hadn't remembered that it addresses nonalcoholic steatohepatitis and not simple fatty liver so it may not be as applicable as I thought. Nevertheless I will post it.
1367899 tn?1278121440 My sister and I started a blog on Adderall to learn more about the medication along with alternative and complementary ADHD treatment options. Any feedback from users of Adderall or Adderall XR would be greatly appreciated. Topics to be added this week on http://Adderall.org How is Adderall XR different from Adderall? [Adderall vs. Adderall XR] What is Adderall? How to Make Adderall: [Adderall Background Information] What are the best Adderall and ADHD books?
Avatar n tn I was watching my local news today and they started talking about VS bras and people experiencing rashes and itching. I can't believe it. For over a year I was to the dermatologist, gynocologist and family doctor trying to get help for the unbelieveable itching that I had on my breasts. I was wearing a VS bra. I went through many topical creams, changed my diet, changed my detergent, even the doctors were baffled. Over the summer I went to VS and got new bras.
Avatar m tn Responders had significantly lower serum cholesterol levels (152±43 Vs 181±33 mg%, P=0.01), lower LDL levels (83±31 Vs 104±29, mg%, P=0.008), lower HDL levels (42±14 Vs 50±10, mg%, P=0.009), and higher vitamin D levels (42.1±6.0 Vs 27.3±5.2 ng/ml, P0.05). Multivariate logistic regression analysis showed that gender (Women, OR 2.3, P< 0.001), low cholesterol levels (180mg/dL; OR 2.5, P< 0.03), low HDL (40 mg/dL, OR 3.5, P< 0.001), and high vitamin D levels ( 20 ng/ml, OR 3.8, P< 0.
Avatar n tn It means you will need to take thyroid medicine. What has your Dr. told you. Mine was 20 last week so my meds were increased I take Levoxyl. The reason mine went so high in my opinion is because I stopped taking the Levoxyl for a month or so. Felt lousy so had my blood tested and voila! Now I return in 6 weeks for another blood test to find the numbers. Maybe I will stay on the dose or it may need to be adjusted. This was my fault for stopping. They told me they like mine around 2.
Avatar m tn The HBsAg clearance rate was significantly greater in the extended therapy group than in the standard therapy group at 24 and 48 weeks post-treatment (33.3% vs. 10.5% and 35.7% vs. 10.5%, respectively; P < 0.05 for both). In addition, patients with an increase of more than 1 log10 IU/ml in HBsAg level from baseline to week 24 had a significantly lower level of HBsAg at end of treatment (0.54 ± 1.76 vs. 2.89 ± 1.27, P < 0.001), but a higher level of HBsAg clearance (64.3% vs. 7.
148588 tn?1465778809 Overall, sustained virological response (SVR) was significantly higher in patients treated with peginterferon plus Chinese herbs than in patients treated with peginterferon alone (81 % vs. 64 %, respectively; odds ratio, 2.60; 95 % confidence interval: 1.32-5.14; p < 0.05). A combined therapy of peginterferon plus Chinese herbs was also superior to peginterferon therapy in achieving an early viral response (EVR, 80 % vs. 70 %, respectively), a viral response at week 24 of treatment (82 % vs.
148588 tn?1465778809 The proportion of patients who achieved SVR with 24 weeks of triple therapy following a lead-in phase was 56% (P = .0005 vs standard of care) vs 54% with 28 weeks of triple therapy and no lead-in treatment (P = .013 vs standard of care). Another important finding concerns the incidence and extent of anemia.